Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 21:1:199.
doi: 10.1038/s42003-018-0202-8. eCollection 2018.

Big bottlenecks in cardiovascular tissue engineering

Affiliations

Big bottlenecks in cardiovascular tissue engineering

Ngan F Huang et al. Commun Biol. .

Abstract

Although tissue engineering using human-induced pluripotent stem cells is a promising approach for treatment of cardiovascular diseases, some limiting factors include the survival, electrical integration, maturity, scalability, and immune response of three-dimensional (3D) engineered tissues. Here we discuss these important roadblocks facing the tissue engineering field and suggest potential approaches to overcome these challenges.

PubMed Disclaimer

Conflict of interest statement

J.C.W. has financial interest in Khoris Biosciences. All the remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Bottlenecks in cardiovascular tissue engineering. These challenges include the survival, electrical integration, maturity, scalability, and immune response of three-dimensional engineered tissues

Similar articles

Cited by

References

    1. Benjamin EJ, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018 doi: 10.1161/cir.0000000000000558. - DOI - PubMed
    1. Tonsho M., Michel S., Ahmed Z., Alessandrini A., Madsen J. C. Heart Transplantation: Challenges Facing the Field. Cold Spring Harbor Perspectives in Medicine. 2014;4(5):a015636–a015636. doi: 10.1101/cshperspect.a015636. - DOI - PMC - PubMed
    1. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–926. doi: 10.1126/science.8493529. - DOI - PubMed
    1. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. doi: 10.1016/j.cell.2007.11.019. - DOI - PubMed
    1. Lian X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat. Protoc. 2013;8:162–175. doi: 10.1038/nprot.2012.150. - DOI - PMC - PubMed